• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

移动性肺部肿瘤的4D质子治疗计划策略

4D Proton treatment planning strategy for mobile lung tumors.

作者信息

Kang Yixiu, Zhang Xiaodong, Chang Joe Y, Wang He, Wei Xiong, Liao Zhongxing, Komaki Ritsuko, Cox James D, Balter Peter A, Liu Helen, Zhu X Ronald, Mohan Radhe, Dong Lei

机构信息

Department of Radiation Physics, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-4009, USA.

出版信息

Int J Radiat Oncol Biol Phys. 2007 Mar 1;67(3):906-14. doi: 10.1016/j.ijrobp.2006.10.045.

DOI:10.1016/j.ijrobp.2006.10.045
PMID:17293240
Abstract

PURPOSE

To investigate strategies for designing compensator-based 3D proton treatment plans for mobile lung tumors using four-dimensional computed tomography (4DCT) images.

METHODS AND MATERIALS

Four-dimensional CT sets for 10 lung cancer patients were used in this study. The internal gross tumor volume (IGTV) was obtained by combining the tumor volumes at different phases of the respiratory cycle. For each patient, we evaluated four planning strategies based on the following dose calculations: (1) the average (AVE) CT; (2) the free-breathing (FB) CT; (3) the maximum intensity projection (MIP) CT; and (4) the AVE CT in which the CT voxel values inside the IGTV were replaced by a constant density (AVE_RIGTV). For each strategy, the resulting cumulative dose distribution in a respiratory cycle was determined using a deformable image registration method.

RESULTS

There were dosimetric differences between the apparent dose distribution, calculated on a single CT dataset, and the motion-corrected 4D dose distribution, calculated by combining dose distributions delivered to each phase of the 4DCT. The AVE_RIGTV plan using a 1-cm smearing parameter had the best overall target coverage and critical structure sparing. The MIP plan approach resulted in an unnecessarily large treatment volume. The AVE and FB plans using 1-cm smearing did not provide adequate 4D target coverage in all patients. By using a larger smearing value, adequate 4D target coverage could be achieved; however, critical organ doses were increased.

CONCLUSION

The AVE_RIGTV approach is an effective strategy for designing proton treatment plans for mobile lung tumors.

摘要

目的

研究使用四维计算机断层扫描(4DCT)图像为移动性肺部肿瘤设计基于补偿器的三维质子治疗计划的策略。

方法与材料

本研究使用了10例肺癌患者的四维CT数据集。通过合并呼吸周期不同阶段的肿瘤体积来获得内部大体肿瘤体积(IGTV)。对于每位患者,我们基于以下剂量计算评估了四种计划策略:(1)平均(AVE)CT;(2)自由呼吸(FB)CT;(3)最大强度投影(MIP)CT;以及(4)将IGTV内的CT体素值替换为恒定密度的AVE CT(AVE_RIGTV)。对于每种策略,使用可变形图像配准方法确定呼吸周期中产生的累积剂量分布。

结果

在单个CT数据集上计算的表观剂量分布与通过合并传递到4DCT各阶段的剂量分布计算的运动校正4D剂量分布之间存在剂量差异。使用1厘米涂抹参数的AVE_RIGTV计划具有最佳的总体靶区覆盖和关键结构保护。MIP计划方法导致不必要的大治疗体积。使用1厘米涂抹的AVE和FB计划在所有患者中均未提供足够的4D靶区覆盖。通过使用更大的涂抹值,可以实现足够的4D靶区覆盖;然而,关键器官剂量增加。

结论

AVE_RIGTV方法是为移动性肺部肿瘤设计质子治疗计划的有效策略。

相似文献

1
4D Proton treatment planning strategy for mobile lung tumors.移动性肺部肿瘤的4D质子治疗计划策略
Int J Radiat Oncol Biol Phys. 2007 Mar 1;67(3):906-14. doi: 10.1016/j.ijrobp.2006.10.045.
2
Impact of planned dose reporting methods on Gamma pass rates for IROC lung and liver motion phantoms treated with pencil beam scanning protons.计划剂量报告方法对笔形束扫描质子治疗的 IROC 肺和肝运动体模的 Gamma 通过率的影响。
Radiat Oncol. 2019 Jun 17;14(1):108. doi: 10.1186/s13014-019-1316-y.
3
The relative accuracy of 4D dose accumulation for lung radiotherapy using rigid dose projection versus dose recalculation on every breathing phase.使用刚性剂量投影与在每个呼吸阶段进行剂量重新计算的4D剂量累积用于肺部放疗的相对准确性。
Med Phys. 2017 Mar;44(3):1120-1127. doi: 10.1002/mp.12069.
4
Dosimetric impact of intrafraction motion for compensator-based proton therapy of lung cancer.基于补偿器的肺癌质子治疗中分次内运动的剂量学影响。
Phys Med Biol. 2008 Jun 21;53(12):3343-64. doi: 10.1088/0031-9155/53/12/019. Epub 2008 Jun 3.
5
Treatment planning and 4D robust evaluation strategy for proton therapy of lung tumors with large motion amplitude.大运动幅度肺部肿瘤质子治疗的计划制定和 4D 稳健性评估策略。
Med Phys. 2021 Aug;48(8):4425-4437. doi: 10.1002/mp.15067. Epub 2021 Jul 17.
6
Dose calculations accounting for breathing motion in stereotactic lung radiotherapy based on 4D-CT and the internal target volume.基于4D-CT和内部靶区体积的立体定向肺部放射治疗中考虑呼吸运动的剂量计算
Radiother Oncol. 2008 Jan;86(1):55-60. doi: 10.1016/j.radonc.2007.11.022. Epub 2007 Dec 20.
7
Dosimetric impact of breathing motion in lung stereotactic body radiotherapy treatment using intensity modulated radiotherapy and volumetric modulated arc therapy [corrected].使用调强放疗和容积旋转调强放疗的肺部立体定向体部放疗中呼吸运动的剂量学影响[已更正]。
Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):e251-6. doi: 10.1016/j.ijrobp.2011.12.001. Epub 2012 Feb 24.
8
Four-dimensional treatment planning for stereotactic body radiotherapy.立体定向体部放射治疗的四维治疗计划
Int J Radiat Oncol Biol Phys. 2007 Sep 1;69(1):276-85. doi: 10.1016/j.ijrobp.2007.04.074.
9
Four-dimensional proton treatment planning for lung tumors.肺癌的四维质子治疗计划
Int J Radiat Oncol Biol Phys. 2006 Apr 1;64(5):1589-95. doi: 10.1016/j.ijrobp.2005.12.026.
10
Comparison of planned dose on different CT image sets to four-dimensional Monte Carlo dose recalculation using the patient's actual breathing trace for lung stereotactic body radiation therapy.比较使用患者实际呼吸轨迹进行的四维 Monte Carlo 剂量重新计算时,不同 CT 图像集上的计划剂量在用于肺部立体定向体部放射治疗中的差异。
Med Phys. 2019 Jul;46(7):3268-3277. doi: 10.1002/mp.13579. Epub 2019 Jun 7.

引用本文的文献

1
Evaluation of proton and carbon ion beam models in TReatment Planning for Particles 4D (TRiP4D) referring to a commercial treatment planning system.参照商业治疗计划系统对粒子4D治疗计划(TRiP4D)中的质子和碳离子束模型进行评估。
Z Med Phys. 2025 May;35(2):218-226. doi: 10.1016/j.zemedi.2023.06.002. Epub 2023 Jul 14.
2
Comparison of 3D and 4D robustly optimized proton treatment plans for non-small cell lung cancer patients with tumour motion amplitudes larger than 5 mm.针对肿瘤运动幅度大于5毫米的非小细胞肺癌患者,比较3D和4D稳健优化质子治疗计划。
Phys Imaging Radiat Oncol. 2023 Jun 24;27:100465. doi: 10.1016/j.phro.2023.100465. eCollection 2023 Jul.
3
Emerging technologies for cancer therapy using accelerated particles.
利用加速粒子的癌症治疗新兴技术。
Prog Part Nucl Phys. 2023 Jul;131:104046. doi: 10.1016/j.ppnp.2023.104046.
4
Management of Motion and Anatomical Variations in Charged Particle Therapy: Past, Present, and Into the Future.带电粒子治疗中运动和解剖变异的管理:过去、现在与未来
Front Oncol. 2022 Mar 9;12:806153. doi: 10.3389/fonc.2022.806153. eCollection 2022.
5
AAPM Task Group Report 290: Respiratory motion management for particle therapy.AAPM 工作组报告 290:粒子治疗中的呼吸运动管理。
Med Phys. 2022 Apr;49(4):e50-e81. doi: 10.1002/mp.15470. Epub 2022 Jan 31.
6
Assessment of a diaphragm override strategy for robustly optimized proton therapy planning for esophageal cancer patients.评估一种膈肌覆盖策略,以实现食管癌患者质子治疗计划的稳健优化。
Med Phys. 2021 Oct;48(10):5674-5683. doi: 10.1002/mp.15114. Epub 2021 Aug 5.
7
Physics of Particle Beam and Hypofractionated Beam Delivery in NSCLC.非小细胞肺癌的粒子束和低分割束输送的物理原理。
Semin Radiat Oncol. 2021 Apr;31(2):162-169. doi: 10.1016/j.semradonc.2020.11.004.
8
Image-Guided Hypofractionated Proton Therapy in Early-Stage Non-Small Cell Lung Cancer: A Phase 2 Study.影像引导下的早期非小细胞肺癌大分割质子治疗:一项2期研究。
Int J Part Ther. 2020 Nov 6;7(2):1-10. doi: 10.14338/IJPT-20-00013.1. eCollection 2020 Fall.
9
Dosimetric impact of geometric distortions in an MRI-only proton therapy workflow for lung, liver and pancreas.MRI 引导质子治疗肺癌、肝癌和胰腺癌中的几何变形对剂量学的影响。
Z Med Phys. 2022 Feb;32(1):85-97. doi: 10.1016/j.zemedi.2020.10.002. Epub 2020 Nov 7.
10
Retrospective Planning Study of Patients with Superior Sulcus Tumours Comparing Pencil Beam Scanning Protons to Volumetric-Modulated Arc Therapy.回顾性研究比较笔形束扫描质子与容积调强弧形治疗肺上沟瘤患者的计划。
Clin Oncol (R Coll Radiol). 2021 Mar;33(3):e118-e131. doi: 10.1016/j.clon.2020.07.016. Epub 2020 Aug 11.